Rare Bladder Disease Assay, Incontinence Treatment Urged
This article was originally published in The Gray Sheet
Discovery of a protein in the urine of interstitial cystitis (IC) sufferers may lead to development of a diagnostic for the disease, according to Vicki Ratner, MD, president of the Interstitial Cystitis Association
You may also be interested in...
FDA approval of Rochester Medical's FemSoft insert for female stress urinary incontinence on Sept. 30, the final day of the federal government's fiscal year, apparently put the agency's total number of approved, original premarket approval applications for the year at 33, down from 42 in 1998 and 46 in 1997.
Inovio forges ahead into Phase I trials with DNA-based vaccine candidate, but can it prove skeptics wrong?
The impact of the coronavirus pandemic on investors’ portfolios was immediately apparent at the end of the first quarter of 2020. Equity market sell-offs are reflections of investors’ concern for future financial performance which, if material, may have to be announced early.